Skip to main content
Premium Trial:

Request an Annual Quote

DNAStar Licenses Lasergene Software to University of Bristol

NEW YORK (GenomeWeb News) — DNAStar has granted the University of Bristol a 3-year site license to its Lasergene sequence-analysis software, DNAStar said today.
The Lasergene software is used to help researchers assemble and analyze protein and DNA sequences.
DNAStar said it has a 15-year relationship with Bristol.
Financial terms of the deal were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.